This paper is only available as a PDF. To read, Please Download here.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Dexamethasone suppression test and CAT abnormalities in schizophrenia.Pharmacopsychiatry. 1988; 21: 56
- Dexamethasone suppression test in positive and negative schizophrenia.Psychiatry Res. 1989; 30: 69-75
- Negative symptoms, DST and variability of response to neuroleptics in schizophrenia.Eur Neuropsychopharmacol. 1993; 3: 205-207
- Prediction of response to haloperidol in schizophrenia: Neuroendocrine, neuromorphological and clinical variables.Int Clin Psychopharmacol. 1994; 9: 3-7
- Hippocampal pathologic findings in schizophrenia.Arch Gen Psychiatry. 1989; 46: 1019-1024
- Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II.Biol Psychiatry. 1995; 38: 803-807
- Symptomatology and cognitive impairment associate independently with post-dexamethasone cortisol concentrations in unmedicated schizophrenic patients.Biol Psychiatry. 1991; 29: 855-864
- Positive and negative symptoms in schizophrenia and the dexamethasone suppression test.Biol Psychiatry. 1989; 25: 788-792
- Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement, and outcome.Biol Psychiatry. 1991; 29: 953-964
Article info
Identification
Copyright
© 1996 Society of Biological Psychiatry. Published by Elsevier Inc.
